Skip to main content

Table 2 Adverse events (all grades)

From: The efficacy of sodium azulene sulfonate L-glutamine for managing chemotherapy-induced oral mucositis in cancer patients: a prospective comparative study

 

GA group

Control group

(n = 34)

(n = 33)

Hematotoxicity, n (%)

 Neutropenia

1 (2.9)

1 (3.0)

 Hemoglobin decrease

3 (8.8)

4 (12.1)

 Thrombopenia

3 (8.8)

2 (6.1)

Non-hematotoxicity, n (%)

 Nausea

9 (26.5)

7 (21.2)

 Vomiting

1 (2.9)

0 (0.0)

 Diarrhea

1 (2.9)

4 (12.1)

 Fever

2 (5.9)

2 (9.1)

Decreased liver function, n (%)

 AST increased

1 (2.9)

1 (3.0)

 ALT increased

1 (2.9)

2 (6.1)

  1. AST aspartate transaminase, ALT alanine transaminase